RU92010334A - CONJUGAT - Google Patents

CONJUGAT

Info

Publication number
RU92010334A
RU92010334A RU92010334/14A RU92010334A RU92010334A RU 92010334 A RU92010334 A RU 92010334A RU 92010334/14 A RU92010334/14 A RU 92010334/14A RU 92010334 A RU92010334 A RU 92010334A RU 92010334 A RU92010334 A RU 92010334A
Authority
RU
Russia
Prior art keywords
phospholipase
antibody
enzyme
conjugat
conjugate
Prior art date
Application number
RU92010334/14A
Other languages
Russian (ru)
Inventor
В.П. Шахов
Original Assignee
Научно-исследовательский институт фармакологии Томского научного центра РАМН
Filing date
Publication date
Application filed by Научно-исследовательский институт фармакологии Томского научного центра РАМН filed Critical Научно-исследовательский институт фармакологии Томского научного центра РАМН
Publication of RU92010334A publication Critical patent/RU92010334A/en

Links

Claims (1)

Коньюгат относится к медицине, в частности к иммунофармакологии, и может быть использовано для диагностических и лечебных целей. Цель изобретения - параллельное расщепление фосфолипидов и взаимодействие с антигенами. Коньюгат представляет собой антитело или его иммуноактивный фрагмент и фермент. Кроме того в качестве фермента используют фосфолипазу, в соотношении антитело - фосфолипаза 1:2, иммуноактивный фрагмент - фосфолипаза 1:4.Conjugate refers to medicine, in particular to immunopharmacology, and can be used for diagnostic and therapeutic purposes. The purpose of the invention is the parallel splitting of phospholipids and interaction with antigens. The conjugate is an antibody or an immunoactive fragment thereof and an enzyme. In addition, phospholipase is used as an enzyme, in the ratio of antibody - phospholipase 1: 2, immunoactive fragment - phospholipase 1: 4
RU92010334/14A 1992-12-07 CONJUGAT RU92010334A (en)

Publications (1)

Publication Number Publication Date
RU92010334A true RU92010334A (en) 1995-02-10

Family

ID=

Similar Documents

Publication Publication Date Title
EA199700413A1 (en) COMPOSITION CONTAINING A VACCINE AND ANTIGEN AND POLYACHARIDE CONJUGATE ADSORBED ON ALUMINUM PHOSPHATE
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
EA199800946A1 (en) CONCENTRATED ANTIBODY PREPARATION
RU94046284A (en) Method for detecting antibodies, method for performing c-cracking of blood components and set for detecting hcv-antibodies
EP0671920A4 (en) An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease.
ES2102007T3 (en) MONOMER AND DIMER ANTIBODY FRAGMENT FUSION PROTEINS.
ATE174689T1 (en) DIAGNOSIS AND TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS
KR900013979A (en) Immunogenic Regions of the Human Papillomavirus Type 16 E7 Protein
RU94024566A (en) Method of modification, method of providing protein binding with antibody, pharmaceutical compositions, method of diagnosis
RU94040856A (en) Vaccine for oral administration
KR890002547A (en) Monoclonal antibodies and peptides for the treatment and diagnosis of HIV infection
AR033832A1 (en) AN EX LIVE METHOD FOR DIAGNOSING AN AUTOIMMUNE DISEASE, ANTIBODY, DIAGNOSTIC COMPOSITION THAT UNDERSTANDS IT, AND USES OF ANTIBODY
KR890700662A (en) Viral antigens and methods for their preparation and methods of use for diagnostic and therapeutic purposes
Rabson et al. Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole
EP0222310A3 (en) Methods for diagnosis and therapy of multiple sclerosis
ES2053669T3 (en) DIAGNOSTIC AGENT AND PROCEDURE FOR THE DETERMINATION OF APOLIPOPROTEIN B.
RU92010334A (en) CONJUGAT
Lesnicar A prospective study of viral hepatitis A and the question of chronicity
RU93048161A (en) COMBINED PEDIATRIC VACCINE WITH STRENGTHENED IMMUNOGENITY OF EACH VACCINARY COMPONENT
SE8705074L (en) SETTING DETERMINING ANTIBODIES AGAINST PALCIPARUM SPOROZOUS
Yoo et al. Lack of antibody activity in human myeloma proteins
Fabro et al. Acetylsalicylic acid allergy and pyrazol allergy, or pseudo-allergy? Results of skin tests and antibody determination in a multicentric study.
BR9307176A (en) Methods for identifying a patient infected with hiv to determine the effectiveness of treatment of a human patient infected with hiv and process for identifying individuals infected with hiv
WO1997035884A8 (en) Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
FI971879A0 (en) Antibodies to allogeneic and xenogeneic proteins, their use in diagnosis and treatment and methods for their determination